The Bill & Melinda Gates Foundation, Novo Nordisk Foundation, and Wellcome are collaborating on a $50 million effort to boost ...

A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: ...

Kolkata: Prices of 42 medicines, including those used for day-to-day consumption, are likely to change following an order by ...

Dalan Animal Health, a global leader in bioscience innovation, today announced a major breakthrough in food production and ...

Research into developing new antimicrobial resistance treatments in Nigeria and other low/middle-income countries has secured ...

Key drivers include strategic alliances and mergers amongst pharmaceutical firms. The global antibiotics market is projected ...

Immunocompromised participants were much more likely to have received at least four doses of COVID-19 vaccine than their ...

Twenty years ago, in 2004, Congress passed the Project BioShield Act, which established the Biomedical Advanced Research and ...

Glox Therapeutics appoints Dr Michael Murray as Chair and Dr Nel Moore as SAB Member to support development of precision ...

Chad Gerlaugh, 46, was admitted to hospital in April 2019 to remove a kidney stone but went on to have his arms and legs ...

Diarrheagenic E. coli (DEC) is a major global cause of diarrheal diseases, with certain strains showing alarming levels of antibiotic resistance.

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.